ZEAL - Zealand Pharma A/S ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Zealand Pharma A/S ADR's activity chart (see below) currently has 29 price targets and 22 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 130.14 days.

Most recent stock forecast was given by from NEEDHAM on 14-Jul-2022. First documented stock forecast 05-Sep-2017.

Best performing analysts who are covering ZEAL - Zealand Pharma A/S ADR:

Alan Carr Graig Suvannavejh David Lebowitz Joseph Stringer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Mar-2022

$32

$14.41 (81.92%)

$32

4 years 2 months ago
(14-Jul-2022)

0/5 (0%)

$17.06 (114.19%)

Buy Since 15-Oct-2019

$41

5 years 5 months 21 days ago
(24-Mar-2021)

2/2 (100%)

$13.45 (48.82%)

93

Buy Since 12-Sep-2018

$44

$26.41 (150.14%)

$45

5 years 10 months 1 days ago
(13-Nov-2020)

10/12 (83.33%)

$6.73 (18.06%)

77

Buy Since 05-Sep-2017

$42

$24.41 (138.77%)

$32

6 years 9 months 30 days ago
(15-Nov-2019)

4/4 (100%)

$10.67 (34.06%)

332

Show more analysts

Please expand the browser size to see the chart

What is ZEAL (Zealand Pharma A/S ADR) average time for price targets to be met?

On average it took 130 days for the stock forecasts to be reached, with an average price target met ratio of 66.67%.

Which analyst most recently updated their price target on ZEAL (Zealand Pharma A/S ADR)?

Which analyst has the most public recommendations on ZEAL (Zealand Pharma A/S ADR)?

has 0 price targets and 0 ratings on ZEAL

Which analyst is the currently most bullish on ZEAL (Zealand Pharma A/S ADR)?

David Lebowitz with the highest potential upside of $26.41

Which analyst is the currently most reserved on ZEAL (Zealand Pharma A/S ADR)?

Graig Suvannavejh with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?